“May all be happy, may all be healed, may all be at peace and may no one ever suffer."
Retinoblastoma is a rare type of cancer that affects the retina, the thin layer of tissue at the back of the eye that is responsible for transmitting visual signals to the brain. Retinoblastoma is most commonly diagnosed in children, and it is one of the most common types of childhood cancer.
The cause of retinoblastoma is not fully understood, but it is believed to be caused by mutations in the genes that control the growth and division of cells in the retina. These mutations can be inherited from a parent or can occur spontaneously during development.
Symptoms of retinoblastoma can include a white glow or white color in the center of the eye, a crossed or lazy eye, and vision problems. Diagnosis typically involves a comprehensive eye exam, including an examination of the retina, and may involve imaging tests such as ultrasound or MRI.
Treatment for retinoblastoma depends on the size and location of the tumor, as well as the extent of cancer. Treatment options may include chemotherapy, radiation therapy, cryotherapy (freezing the tumor), laser therapy, or surgery to remove the affected eye. In some cases, a combination of treatments may be used.
Early diagnosis and treatment are important in achieving a good outcome for patients with retinoblastoma. Children who have been diagnosed with retinoblastoma may require ongoing monitoring to detect any potential recurrence or complications from treatment. Additionally, genetic counseling may be recommended for families who have a history of retinoblastoma.
Retinoblastoma occurs when nerve cells in the retina develop genetic mutations. These mutations cause the cells to continue growing and multiplying when healthy cells would die. This accumulating mass of cells forms a tumor.
Retinoblastoma cells can invade further into the eye and nearby structures. Retinoblastoma can also spread (metastasize) to other areas of the body, including the brain and spine.
For most instances of retinoblastoma, it's not clear what causes the genetic mutation that leads to cancer. However, it's possible for children to inherit a genetic mutation from their parents.
Gene mutations that increase the risk of retinoblastoma and other cancers can be passed from parents to children.
Hereditary retinoblastoma is passed from parents to children in an autosomal dominant pattern, which means only one parent needs a single copy of the mutated gene to pass the increased risk of retinoblastoma on to the children. If one parent carries a mutated gene, each child has a 50% chance of inheriting that gene.
Although a genetic mutation increases a child's risk of retinoblastoma, it doesn't mean that cancer is inevitable.
Children with the inherited form of retinoblastoma tend to develop the disease at an earlier age. Hereditary retinoblastoma also tends to occur in both eyes, as opposed to just one eye.
Doctors aren't sure what causes most instances of retinoblastoma, so there's no proven way to prevent the disease.
If your child is diagnosed with retinoblastoma, your doctor may recommend genetic testing to determine whether the cancer was caused by an inherited gene mutation. Your doctor may recommend that you meet with a genetic counselor who can help you decide whether to undergo genetic testing.
Genetic testing enables families to know whether their children may have an increased risk of retinoblastoma, so medical care can be planned accordingly. For instance, eye exams may begin soon after birth or, in some situations, before a baby is born. That way, retinoblastoma may be diagnosed very early — when the tumor is small and a chance for a cure and preservation of vision is still possible.
Genetic testing can be used to determine whether:
The best treatments for your child's retinoblastoma depend on the size and location of the tumor, whether cancer has spread to areas other than the eye, your child's overall health, and your own preferences. The goal of treatment is to cure the cancer. When possible, doctors try to choose treatments that won't result in removal of the eye or a loss of vision.
Chemotherapy is a drug treatment that uses chemicals to kill cancer cells. In children with retinoblastoma, chemotherapy may help shrink a tumor so that another treatment, such as cryotherapy or laser therapy, may be used to treat the remaining cancer cells. This may improve the chances that your child won't need surgery to remove the eye.
Types of chemotherapy used to treat retinoblastoma include:
Radiation therapy uses high-powered energy, such as X-rays and protons, to kill cancer cells. Types of radiation therapy used in treating retinoblastoma include:
During laser therapy, a heat laser is used to directly destroy the tumor cells.
Cryotherapy uses extreme cold to kill cancer cells.
During cryotherapy, a very cold substance, such as liquid nitrogen, is placed in or near the cancer cells. Once the cells freeze, the cold substance is removed and the cells thaw. This process of freezing and thawing, repeated a few times in each cryotherapy session, causes the cancerous cells to die.
When the cancer is too large to be treated by other methods, surgery to remove the eye may be used to treat retinoblastoma. In these situations, eye removal may help prevent the spread of cancer to other parts of the body. Eye removal surgery for retinoblastoma includes:
Side effects of surgery include infection and bleeding. Removing an eye will affect your child's vision, though most children will adapt to the loss of an eye over time. Your child may need to wear special shatter-resistant glasses and sport goggles at all times to protect the remaining eye.
Clinical trials are studies to test new treatments and new ways of using existing treatments. While clinical trials give your child a chance to try the latest in retinoblastoma treatments, they can't guarantee a cure.
Ask your child's doctor whether your child is eligible to participate in clinical trials. Your child's doctor can discuss the benefits and risks of enrolling in a clinical trial.